Toxicology is a broad church with many subspecialities.  In order to provide its members with the most appropriate forum for discussion the bts has created a number of Speciality Sections.  The aim of these Sections is to provide networking opportunities as well as offering members the chance to propose symposia and workshops for inclusion in the scientific programme at the bts Annual Congress.  Each Speciality Section has a Chair who represents the Section on the Scientific Subcommittee (SSC).

If you would like to suggest a symposium, workshop or another Speciality Section please contact bts@execbs.com with your idea.

The current Speciality Sections are:

Discovery Toxicology

Chair: Dr Pete Newham 
The development of novel compounds for human exposure, particularly pharmaceuticals and personal care products, requires evaluation of the risk they pose to human health and wellbeing. It is now widely accepted that earlier identification of unacceptable safety or toxicological risks during the discovery and pre-clinical phases of the development cycle is a significant objective, ethically, financially, and in terms of optimal compound selection. Discovery Toxicology is the discipline focused on predictive toxicological and safety evaluation studies to provide an integrated evaluation of both target-related and chemical-related safety liabilities prior to advancement of compounds into non-clinical and clinical development. The aim of the BTS Discovery Toxicology Speciality Section is to provide a forum to foster discussion and dissemination of emerging technologies, predictive toxicology, and safety assessment methodologies with utility in a discovery research environment. This speciality section also acts as a central focus for the identification of gaps in these novel and emerging technologies and provision of guidance and education around appropriate application of these approaches to refine or compliment current toxicological practices and frameworks used in research and development.

Human Toxicology

Chair: Dr John Thompson
The Human Toxicology Section consists of BTS members whose interests encompass a wide range of topics, reflecting an interest in toxicology as it relates to individuals, populations and society as a whole. It attracts individuals from industry, regulatory bodies and academic institutions as well as those interested in occupational medicine, clinical toxicology and epidemiology.
The section’s wide-ranging interests are reflected in the recent symposia which it has organised, including sessions on Drug Abuse in Sport, Food Allergy and Intolerance, Epigenetics, Herbal Medicines and Genetic Polymorphism: Susceptibility to Occupational Disease.
Members of the section include those with interests in fundamental mechanisms of toxicity, through to those who apply these principles daily to individuals within the fields of occupational, regulatory and clinical toxicology.  Membership of the Section is open to all BTS members that are interested in the field, irrespective of background or experience.
The section offers the opportunity to interact with others who hold similar interests, and to propose and organise symposia held within the annual meeting.  If you are interested in Human Toxicology in its broadest sense then come and join the section!

Regulatory Toxicology

Chair: Dr Henry Stemplewiski
The goal of the Regulatory Toxicology Section is to promote toxicology regulations founded on sound science. The future can be expected to bring scientific innovation at an increasing rate in many fields of toxicology. The regulations should not impede scientific progress whilst at the same time they must fulfil their primary role of protecting public health. The Section aims to facilitate this process by providing a key forum for the exchange of views on future developments in the scientific and regulatory arena. The Section aims to facilitate this process by providing a key forum for the exchange of views on future developments in the scientific and regulatory arena. The topicality and diversity of the topics addressed by the Section is demonstrated by the many symposia run by the Section. The Section continues to be very active and is running a symposium on the development and safety of stem cell therapies at the Annual Congress in April 2014. The Section aims to be relevant to all sectors of the BTS membership including those in the pharmaceutical, industrial chemical, food and agrochemical industries. Similarly, the Section aims to be of relevance to the regulatory agencies, the industry, the research organisations and academia. The Section welcomes suggestions for future activities from all BTS members to ensure that the needs of the membership of the BTS are met.

Risk Assessment

Chair: Dr Carol Courage
The Risk Assessment speciality section is made up of a very diverse group of toxicologists from both industry and academia and from across all the expertise areas of toxicology. The aim of the group is to promote an understanding of risk assessment, current techniques and approaches. The science of toxicology is continually evolving and we aim to keep abreast of the science and communicate how the science impacts our risk assessment methodology. The group has had a symposium at every annual meeting since its establishment in 2005. We are always looking for new and enthusiastic members, so let me know if you would like to join us!